National Viral Hepatitis Education, Awareness, and Capacity Building for Communities and Providers | CDC RFA PS21 2105

Opportunity Information: Apply for CDC RFA PS21 2105

The National Viral Hepatitis Education, Awareness, and Capacity Building for Communities and Providers grant opportunity (CDC RFA PS21-2105) is a CDC cooperative agreement under the U.S. Department of Health and Human Services, administered through CDCs National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP). It is designed to reduce illness and deaths linked to chronic hepatitis B and chronic hepatitis C by expanding testing among populations most affected and improving linkage to appropriate care and treatment. Rather than funding a single set of activities, the program is structured around two distinct components with different audiences and deliverables: Part A focuses on community-facing coalition building and education, and Part B focuses on professional education and training for health care providers.

Part A, titled Community Education and Awareness and Capacity Building, centers on leading and expanding an existing national coalition that reaches communities or geographic areas experiencing high rates of viral hepatitis. The intent is to strengthen a coordinated network that can spread effective approaches quickly and consistently across multiple organizations. Core expectations for the coalition include sharing practical strategies, educational materials, and lessons learned across members; providing technical assistance so member organizations can deliver culturally competent outreach; building members capacity to support testing for the target populations; and actively engaging coalition members in implementing CDC education campaigns. In other words, Part A is meant to create a multiplier effect: a well-supported coalition that can tailor outreach to local cultural and language needs while still aligning with national public health messaging and best practices.

The outcomes CDC is looking for under Part A are specific and measurable. First, the coalition itself should grow in both size and capability, with more member organizations able to deliver culturally competent education and outreach. Second, more people living with chronic hepatitis B and/or chronic hepatitis C should become aware of their infection, reflecting progress toward earlier diagnosis through education-driven testing and engagement. Third, the program aims to increase exposure to CDCs hepatitis education campaigns, meaning the coalitions work should amplify and extend CDC messaging into communities that might otherwise be missed by traditional communication channels.

Part B, titled Professional Education/Training, targets the provider side of the problem by improving the knowledge and practical skills of health professionals who screen, diagnose, and manage hepatitis B and hepatitis C. The required work involves developing web-based, on-demand training materials that are free to access, accurate, current, and comprehensive. A key feature is that these offerings must be Continuing Education accredited, which helps ensure the training is recognized, used, and integrated into professional development requirements. The training products are intended to be usable at any time, making them accessible to busy clinicians and public health professionals who need reliable guidance on evolving standards of care.

The outcomes for Part B emphasize workforce readiness and quality of care. CDC expects increases in provider knowledge and skills, including improved ability to screen appropriately, make correct diagnoses, medically manage chronic viral hepatitis, and provide ongoing care. In practical terms, this component is meant to reduce gaps in clinical practice that can delay diagnosis or prevent patients from receiving effective treatment, especially in settings where hepatitis expertise is limited.

Administratively, the opportunity is categorized as discretionary funding and uses a cooperative agreement mechanism, which typically means CDC anticipates substantial involvement in the project through collaboration, guidance, and programmatic oversight. Eligibility is listed as unrestricted (open to any type of entity), subject to any additional eligibility language in the full notice. The opportunity was created March 15, 2021, with an original application deadline of May 14, 2021, and required electronic submission by 11:59 p.m. Eastern Time on the due date. CDC anticipated making two awards. The listing includes an award ceiling of 0, which generally indicates the ceiling was not specified in the summary field and would need to be confirmed in the full NOFO for exact funding levels and budget expectations.

• The Department of Health and Human Services, Centers for Disease Control - NCHHSTP in the health sector is offering a public funding opportunity titled "National Viral Hepatitis Education, Awareness, and Capacity Building for Communities and Providers" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.270.
• This funding opportunity was created on Mar 15, 2021.
• Applicants must submit their applications by May 14, 2021 Electronically submitted applications must be submitted no later than 1159 p.m., ET, on the listed application due date.. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• The number of recipients for this funding is limited to 2 candidate(s).
• Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.

Apply for CDC RFA PS21 2105

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: